[Continuous extra-amniotic intracavitary application of prostaglandin F2 alpha for medicamentous induction of labour in high-risk cases of pregnancy interruption].
Reported in the paper is continuous extra-amniotic application of Prostaglandin F2 alpha (PG F2 alpha) to 70 juvenile primigravidae for termination of pregnancy. Successful priming was achieved in 54 patients after three and a half hours of induction, following administration of an average induction dose of 3 mg PG F2 alpha. Induced abortion was "incomplete or retained" and, therefore, stopped in 16 cases. An account is given of advantages of the above approach over intermittent  intra-uterine application. The technique described in this paper was found to be suitable and commendable for minimizing of side-effects and risk as well as for better and individual controllability. It has also proved to reduce the variety of contra-indications to prostaglandin induction for patients with pre-existing diseases. Continuous intracavitary induction of labour may be considered as a justified alternative to the risks implied in other techniques of interruption.
D000029:Abortion, Legal; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D015237:Dinoprost; D005260:Female; D005859:Germany, East; D006801:Humans; D007751:Labor, Induced; D010298:Parity; D011247:Pregnancy; D011460:Prostaglandins F / Q000008:administration & dosage*
D011460:Prostaglandins F; D015237:Dinoprost
Anwendung der kontinuierlichen extraamnialen intrakavitären Prostaglandin F2 alpha-Applikation zur medikamentösen Weheninduktion bei Risiko-Interruptiofällen.